November 3, 2023
New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® De novo Cloning and Amplification kit on the BioXp 3250 and BioXp 9600 systems. This cell-free [...]
Evident Aligns Business Unit Structure to Best Meet Customer Needs
November 3, 2023
Evident was established as a standalone company in April 2023, comprising the former Scientific Solutions business of Olympus, marking a significant milestone in the development of our new company. Building on our proven track record of innovation in imaging, instrumentation, and measurement solutions, we are excited to announce we have reorganized our internal structure into [...]
November 3, 2023
Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome SEATTLE -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the expansion of its research and development senior [...]
Genomic Vision Requests Receivership Proceedings
November 3, 2023
BAGNEUX, France, Genomic Vision (FR0011799907 – GV, the "Company"), a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of transformed cells, announces having filed today a declaration of cessation of payments ("déclaration de cessation des paiements") with the Commercial Court of Nanterre. The employee representative bodies were informed on October [...]
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
November 2, 2023
Consortium Aims to Share Best Practices and Increase our Understanding of Genetic Disease MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the creation of the HiFi Solves consortium. This global consortium brings together researchers from 15 leading genomics research institutions across 11 countries to study the value HiFi-based [...]
November 2, 2023
Partnership combines QIAGEN’s QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element’s AVITI System users in genomic analysis Collaboration to accelerate discovery, enhance cost efficiencies, and improve turnaround times for genomic applications in the scientific community QIAGEN to present performance data for universal QIAseq library preparation panels running on other sequencing platforms at [...]
November 2, 2023
Company has signed virtual power purchase agreements (VPPAs) for a total of around 300 gigawatt hours (GWh) of renewable energy per year. Company signs virtual power purchase agreements for 300 gigawatt hours per year Wind and solar farms operational in Spain from 2025 Important milestone for strategic sustainability goal of Merck KGaA, Darmstadt, Germany, to [...]
November 2, 2023
DKSH has signed an agreement to acquire Bio-Strategy Limited (“Bio-Strategy”), the largest independent distributor of scientific instruments in Australia and New Zealand. With this acquisition, DKSH grows its Scientific Instrumentation business in line with Business Unit Technology’s strategy to build resilience and deliver profitable growth. Zurich, Switzerland – DKSH has announced today that it signed [...]
November 2, 2023
SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in Thompson and Thompson Genetics and Genomics in Medicine, 9th edition, a textbook regularly used for medical students, genetic counseling students, students in laboratory medicine, and more advanced trainees pursuing American Board of Medical Genetics and [...]
Stellaromics Secures $25 Million in Series A Funding to Advance 3D Spatial Multi-omic Profiling
November 2, 2023
Life Sciences Pioneer Todd Dickinson, Ph.D., Appointed as CEO; Spatial Biology Innovator Ye Fu, PhD., Appointed as CTO Boston – Stellaromics, a leading provider of in situ spatial multi-omics technology, today announced that the company has raised $25 million in a Series A financing round. The Series A financing round included Plaisance Capital Management and [...]

